For almost three decades, Acepac International has continually diversified its markets and expanded its footprint, including being appointed as an authorized agent of Inmark’s brand of temperature control packaging products.
Acepac International offers a wide variety of packing products, packing material, Ecommerce packaging and fulfilment services. (Credit: Devanath from Pixabay)
Inmark, a Novvia Group company backed by Kelso & Company, has acquired a majority interest in the Shanghai operations of Acepac International, to support its Life Sciences Division.
With their 10-year strong partnership in China, the combination of Acepac and Inmark in the Asia Pacific region will provide for a more robust product offering and expanded geographic footprint to better serve the critical needs of their combined customer bases.
Acepac International, founded in Singapore in 1994, offers a wide variety of packing products, packing material, Ecommerce packaging and fulfilment services. For almost three decades, Acepac International has continually diversified its markets and expanded its footprint, including being appointed as an authorized agent of Inmark’s brand of temperature control packaging products.
“Acepac has been a trusted strategic partner to Inmark in the Asia Pacific region for over a decade. We are excited about the enhanced product and service offerings this acquisition brings to our existing clients, as well as the tremendous growth opportunities this alliance provides Inmark in the region,” said Frank Orvino, President of Inmark.
For over 45 years, Inmark has been a trusted source for rigid container, temperature-controlled, specimen transport, used medical device, and dangerous goods packaging.
Headquartered in Atlanta, GA with locations in Europe, Asia, and North America, Inmark has become a respected leader in developing packaging solutions for businesses globally.
Source: Company Press Release